Web Query Tool
Generate customized maps and tables of California cancer incidence or mortality rates.
Quick Links for More Information on Meaningful Use
- CMS Website
- CDC Meaningful Use F.A.Q
- Meaningful Use Resources to Get Started
- Electronic Health Record (EHR) Incentive Program FAQs
Meaningful Use 2: Cancer Reporting in California
The California Department of Public Health (CDPH) is coordinating all reporting for Meaningful Use (MU) for California. CDPH is utilizing a Health Information Exchange (HIE) Gateway to receive and process MU files. For more information on the CDPH HIE Gateway, please go to http://hie.cdph.ca.gov.
To participate in MU2 for Cancer Reporting, Physician Offices (PO) must have successfully participated in MU1, cancer data must meet the HL7 Clinical Document Architecture (CDA) 2.0 standard, and messages must conform to the CDA implementation specifications found in the Implementation Guide for Ambulatory Healthcare Provider Reporting to Central Cancer Registries (PDF, 1.9 MB). In addition, the technology used by the PO to generate the HL7 CDA .XML message has to be a federally certified 2014 Edition EHR technology.
There are four transmission options for submitting MU2 data for Cancer Reporting:
- File Upload via Hypertext Transfer Protocol Secure (HTTPS) – CCR
- Secure File Transfer Protocol (SFTP)
- Public Health Information Network Messaging System (PHINMS) or
- Simple Object Access Protocol (SOAP)
If you do not know your transport method, please ask your Information Technology representative or your Electronic Health Record vendor prior to enrolling to submit MU2 cancer data.
Instructions for Enrolling in MU2 Cancer Reporting
Step 1: Register with the CDPH HIE Gateway
If you have already registered with the CDPH HIE Gateway, log in to your account at https://hiegateway.cdph.ca.gov, click on the My Submissions tab, then skip to Step 5, item 2.
- Register at the CDPH HIE Gateway by “Creating a New Account” at: https://hiegateway.cdph.ca.gov/Account/Register.aspx
- You will receive an email from HIEHelp@cdph.ca.gov requesting confirmation of your registration.
Step 2: Confirm your Email Address and Registration
Click on the link provided in the email you received from HIEHelp@cdph.ca.gov. You will be taken to one of the web pages shown below:Example 1
Click on the link provided at the end of the sentence below and move to Step 3.
Or the Log In screen will come up first…log in with the Username and Password you just created and the screen shown below will appear and you will Click on the Step 3 link.
Step 3: Complete Your Contact Information
- Complete the information and Click the “Submit” button.
- You will be taken back to the “Home” page so you can complete Step 4…proceed with Step 4 below.
Step 4: Complete Your Submitter Organization Information
- On the Home web page, Click the link for Step 4:
- After you Click the link for Step 4, the following screen will appear:
- Submitter Type - Currently the Submitter Type options do not meet our needs at the CCR but it is a required question so please select the first response in the drop-down.NPI Number - Please provide the NPI number for the provider that will be submitting their data.4. Click the link provided and you will move to Step 5 below
Organization Name – Please provide the providers name or the name of the practice.
Contact Information – Please complete the four contact information boxes.
For the next question, “Is this organization currently…”, please select No as your response and Click Submit.
The following screen will appear:
Step 5: Enroll for Cancer Reporting
- You will be taken to a “Manage Submissions” web page as shown below:
- Click the “Enroll” button next to California Cancer Registry (CCR) and the screen on the next page will appear:
It is not indicated as such but all the fields are required for you to submit this screen. Please use the following information to help you with the information being asked:
When finished, Click “Submit”
- What is the name (version) of the EMR/EHR software used by this organization?
- Are you using Modernizing Medicine, Epic, Nextgen Health Care or some other electronic medical record software…please enter the name here or enter Unknown.
- Which vendor developed the EMR/EHR software used by this organization?
- Please answer same as the first question above.
- Is this EMR/HER certified?
- Select Yes or No…if you don’t know select “No”
- Can this EMR/EHR send HL7 CDA formatted data?
- This question also refers to .XML data. If your software vendor sends messages via HL7 or .XML…select “Yes”, if you don’t know, select “No”
- For the remaining six questions, enter the information if known or enter “unknown”.
You will be taken back to the Home web page and it will show that you are 50% complete, do not let this worry you, you have completed all the required steps on the HIE web site.
You will receive an email from HIEHelp@cdph.ca.gov such as shown on the next page:
This email erroneously states that your information will be reviewed and to await word on your eligibility, this is not accurate. Once you have reached this step, you are ready to move forward with reviewing the options available to you for submitting your MU2 cancer data.
Step 6: Testing/Validation
Now that you are Registered and Enrolled with the CDPH HIE Gateway, you are ready to make the decision how you want to submit your MU2 cancer data. There are three options available to you that will allow the data to go directly to the CCR;
- California Cancer Registry Physician Office Web Portal
- Secure File Transfer Protocol (SFTP)
- Public Health Information Network Messaging System (PHINMS)
You also have the option of using Simple Object Access Protocol (SOAP) working directly with the HIE Gateway. Please select the options above on our web site (INSERT HYPERLINK) and select an option that best serves your office. Once a decision is made you can submit a test file and enter the data validation phase of the process. If issues arise during the validation of the data, staff will communicate with you via email or telephone. Once it is verified that your data is structurally valid, you will receive an email from CCR with instructions for Ongoing Data Submission.
Step 7: Ongoing Data SubmissionYou can begin ongoing data submission in compliance with MU2 for Cancer Reporting.
While actively engaged in steps 1 – 5 above, you will be receiving emails and possibly telephone calls from CDPH HIE and CCR. You should maintain copies of these communications for EHR Incentive Program audit purposes.
If you have any questions regarding these processes, you can contact our office at MU2CCRHelp@ccr.ca.gov
Cancer Reporting Requirements:
Dermatologists are required by law to report all new cases of melanoma to their regional cancer registry.
Please Note: This reporting requirement is separate from the Medicare Physician Quality Reporting System (PQRS), and is mandated by California Health and Safety Code, Section 103885 and California Code of Regulations, Section 2593. These laws require that all cases of melanoma be reported to CCR when diagnosed by a health care provider, laboratory, or hospital. Required reporting enables California to identify disease trends, track disease outbreaks, and aid in preventive measures.
To report new cases of melanoma use the following form:
Below are the MU2 requirements for skin cancers. This information is in California’s Volume I., Section II.1.4 – II.1.4.1-II.1.4.2
Reportable Skin Cancers Include:
- Skin cancers in the genital sites (any histology) (vagina (C52.9); clitoris (C51.2); labium (C51.0); vulva (C51.9); prepuce (C60.0); penis (C60.9) and scrotum (C63.2) are reportable.
- Malignant tumors of the skin such as
- adnexal carcinomas (e.g., carcinomas of the sweat gland,
- sebaceous gland,
- ceruminous gland, and hair follicle,
- melanomas including the following
- Early melanoma insitu*
- Evolving melanoma insitu*
- Merkel cell tumors
- Any carcinoma arising in a hemorrhoid is reportable since hemorrhoids arise in mucosa, not in the skin.
Non-Reportable to the Cancer Registry:
- Basal cell carcinomas of the skin
- Epithelial carcinomas of the skin
- Papillary carcinomas of the skin
- Squamous cell carcinomas of the skin
- Early Melanoma
- Evolving Melanoma
NOTE: The term “insitu” must be included in diagnosis in order for early and evolving melanoma insitu to be reportable
- EHR Incentive Program MU Stage1 Requirements Overview [PDF, 1MB]
- Stage 1 Eligible Professional Meaningful Use Table of Contents [PDF, 114KB]
- EP Attestation Worksheet [PDF, 365KB]
- Hospital Attestation Worksheet [PDF, 345KB]
- CAH Payment Tip Sheet [PDF, 188KB
Stage 2 Overview and Measures
Stage 2 Regulations
- Stage 2 Overview Tipsheet
- Stage 2 Guide for Eligible Professionals
- Stage 2 Meaningful Use Specification Sheet Table of Contents for Eligible Professionals
- Stage 2 Meaningful Use Specification Sheet Table of Contents for Eligible Hospitals and CAHs
- Stage 2 Data Sharing Tipsheet for Eligible Professionals
- Security Risk Analysis Tipsheet for Eligible Professionals
- Stage 2 Worksheet for Eligible Professionals
- Stage 2 Worksheet for Eligible Hospitals
- Patient Electronic Access Tipsheet
- Clinical Decision Support Tipsheet
- Public Health Registry Tipsheet
- Stage 2 Meaningful Use Final Rule
- 2014 Standards and Certification Final Rule
- Stage 2 Correction Notice
Office of the National Coordinator of Health IT (ONC) EHR Resources
- Provider User Guide for NIST EHR Randomizer Tool
- Stage 1 Reference Grid: Stage 1 meaningful use objectives for 2014 Certified EHR Technology and correlated certification criteria and standards
- Stage 2 Reference Grid: Stage 2 meaningful use objectives for 2014 Certified EHR Technology and correlated certification criteria and standards